Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- Nanyang Technological University
- National University of Singapore
- RMIT UNIVERSITY
- Harvard University
- NTNU - Norwegian University of Science and Technology
- Nature Careers
- Trinity College Dublin
- University of Oslo
- University of South-Eastern Norway
- AbbVie
- CSIRO
- Center for Drug Evaluation and Research (CDER)
- INESC ID
- Lawrence Berkeley National Laboratory
- OsloMet
- RMIT University
- Singapore University of Technology & Design
- University of Agder
- University of Colorado
- University of Michigan
- University of Saskatchewan
- 11 more »
- « less
-
Field
-
translational questions, including but not limited to drug efficacy and safety prediction, mechanism-of-action inference, biomarker discovery, causal or network-based modeling of biological systems, and drug
-
research projects in computer vision, machine learning, AI, and robotics. Projects may include physically-grounded AI guidance agents, modeling of multimodal data, and generative AI systems for situated
-
interdisciplinary pipelines to identify effective RNA drugs against human diseases: AI-driven RNA discovery – using AI agents to prioritize the therapeutic potential of human lncRNAs (supported by the NHLBI
-
World Asset Develop new agentic AI and large language models (LLMs) to support the algorithm designs for Real World Asset applications and ecosystems. Implement and test the Real World Asset framework
-
including multiple and embodied AI agents. Countering the current trends of very large models with hard-to-control outputs, we will focus on balancing data-based approaches with artists’ knowledge and search
-
study its impact on the degree of collaboration in hybrid teams. The successful candidate will: Develop algorithms to model team performance based on interpersonal (e.g., monitoring, communication) and
-
but not limited to drug efficacy and safety prediction, mechanism-of-action inference, biomarker discovery, causal or network-based modeling of biological systems, and drug repurposing or design
-
for high resolution imaging, developing computational models of islet blood flow changes; characterizing and applying novel ultrasound contrast agents including molecular targeted agents; and use of contrast
-
partners at NVIDIA and Dell to prepare high-impact workflows for 12,000+ NERSC users. What You Will Do: Contribute to one or more NESAP AI-based scientific workflows targeting NERSC HPC resources, edge
-
processes and their associated mass transfer phenomena without and with chemical reaction. Demonstrated understanding of and/or practical or modelling experience with liquid absorbent-based CO2-capture